Lemieux's Lab
Lemieux's Lab
News
Members
Projects
Publications
Collaborations
In the media
Contact us
English
Français
Jean-Francois Spinella
Latest
Identification of Acute Myeloid Leukemia Cell Surface Therapeutic Targets Using Single Cell RNA Sequencing Supported By Surface Proteomics
Identification of Novel Cell Surface Therapeutic Targets for KMT2A-Rearranged Acute Myeloid Leukemia
IL1R1 Expression Predicts the Benefit from Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Intermediate-Risk Cytogenetics
Targeting PLZF Enhances Glucocorticoid Sensitivity in Acute Myeloid Leukemia
Exploring glucocorticoid sensitivity modulators in human acute myeloid leukemia
Genetic characterization of ABT-199 sensitivity in human AML
High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML
Surface proteomics reveals novel potentiel AML antigens for immunitherapeutic targeting
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
Chemogenomic Approach Unveils the Increased Susceptibility of RUNX1-Mutated AML to Glucocorticoids
Chemogenomic Profiling of Complex Karyotype AML Reveals a Novel Susceptibility to G2/M Checkpoint Inhibition Mediated By HMGA2 Overexpression
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of Mitochondrial Vulnerability in Acute Myeloid Leukemia
Cite
×